期刊文献+

子宫动脉栓塞术在子宫腺肌病方面的临床疗效和应用价值 被引量:3

The Applicationg Value and Clinical Curative Effect of Uterine Arterial Embolization in Treatment of Uterine Gland
下载PDF
导出
摘要 目的探讨子宫动脉栓塞术在子宫腺肌病方面的临床疗效和应用价值。方法对45例根据临床症状及B超确诊为子宫腺肌病的患者行子宫动脉栓塞术(UAE)治疗,术后观察其痛经程度、月经量及子宫体积变化。结果 45例患者共接受45次UAE治疗,全部行双侧子宫动脉栓塞治疗,治疗成功率100%。术后随访6-24个月,无1例并发症发生;40例术后痛经完全消失,5例缓解;彩色超声检查子宫体积缩小。结论子宫动脉栓塞术治疗子宫腺肌病因其创伤小、安全性好及并发症少等优点,为本病的治疗开辟了一个新的微创治疗途径。 Objective To investigate the clinical effect and application value of uterine artery embolization in the treatment of uterine gland disease.Methods 45 patients were treated with uterine artery embolization,and the changes of the degree of dysmenorrhea,menstrual volume and uterine volume were observed after operation.Results 45 patients received 45 UAE treatment,all patients underwent bilateral uterine artery embolization,the success rate of embolization was 100%.The patients were followed up for 6 to 24 months,no complications occurred in 40 cases,1 cases of dysmenorrhea disappeared completely,5 cases were relieved obviously,the volume of uterine volume was significantly decreased.Conclusion Uterine artery embolization for treatment of uterine gland muscle has the advantages of less trauma,good safety and less complications.It has opened up a new minimally invasive treatment for the treatment of this disease.
出处 《中国继续医学教育》 2016年第2期72-73,共2页 China Continuing Medical Education
关键词 子宫动脉栓塞 子宫腺肌病 Uterine artery embolization Womb gland myopathy
  • 相关文献

参考文献5

二级参考文献19

  • 1周龙书,戚潜辉,彭菊兰.GnRH-a治疗子宫内膜异位症对患者血清激素及骨密度的影响[J].广东医学,2006,27(6):915-916. 被引量:15
  • 2曾婕.子宫肌瘤介入治疗的护理[J].医用放射技术杂志,2007(5):61-62. 被引量:7
  • 3Lee S L, Chang C Y, Chen P H, et al. A cumulative strategy of GnRH agonist, clomiphene citrate, and GnRH antagonist in a patient with recurrent endometriosis and re- peated aspiration[J]. Taiwan J Obstet Gynecol, 2011,50 (3) : 366-369.
  • 4Khan K N, Kitajima M, Hiraki K, et al. Changes in tis- sue inflammation, angiogenesis and apoptosis in endome- triosis, adenomyosis and uterine myoma after GnRH ago- nist therapy[J]. Hum Reprod,2010, 25(3) :642-653.
  • 5Khan K N, Kitajima M, Hiraki K, et al. Cell prolifera- tion effect of GnRH agonist on pathological lesions of women with endometriosis, adenomyosis and uterine my- oma[J]. Hum Reprod, 2010, 25(11) :2878-2890.
  • 6Khan K N, Kitajima M, Hiraki K, et al. Changes in tis- sue inflammation, angiogenesis and apoptosis in endome- triosis, adenomyosis and uterine myoma after GnRH ago- nist therapy[J]. Hum Reprod, 2010, 25 (3) :642-653.
  • 7Kim N Y, Ryoo U, Lee D Y, et al. The efficacy and tol- erability of short-term low-dose estrogen-only add-back therapy during post-operative GnRH agonist treatment for endometriosis[J]. Eur J Obstet Gynecol Reprod Biol, 2011, 154(1) :85-89.
  • 8Barbieri R L. Endometriosis and the estrogen threshold theory. Relation to surgical and medical treatment[J].J Reprod Med, 1998, 43 (3 Suppl) :287-292.
  • 9Akira S, Mine K, Kuwabara Y, et al. Efficacy of long- term, low-dose gonadotropin-releasing hormone agonist therapy (draw-back therapy) for adenomyosis[J]. Med Sci Monit, 2009, 15(1) :CR1-4.
  • 10Surrey E S. Gonadotropin-releasing hormone agonist and add-back therapy: what do the data show? [J]. CUlT Opin Obstet Gynecol, 2010, 22 (4) :283-288.

共引文献56

同被引文献21

引证文献3

二级引证文献6

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部